CATXPerspective Therapeutics, Inc.
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−25% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −25% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CATX is trading
Perspective Therapeutics, Inc. is −22% over the past year while the S&P 500 is +18%: 40 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −25%
vs 200-day average · a clear downtrend
- RSI (14)
- 45
RSI (14) · neutral
- Below its 52-week high
- 52%
Below its 52-week high
Details›
- Last close2026-10-08
- $2.71
- 1 monthS&P 500 +1.6%
- −9.1%
- 1 yearS&P 500 +18%
- −22%
- 5 yearsS&P 500 +86%
- −57%
- vs 50-day average$2.94
- −7.9%
- 52-week high
- $5.65
- 52-week low
- $2.05
- Annualised volatility
- 106%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$1.3M
| Year | Return |
|---|---|
| 2026 (year to date) | −1.5% |
| 2025 | −14% |
| 2024 | −20% |
| 2023 | +60% |
| 2022 | −36% |
| 2021 | −13% |
| 2020 | −27% |
| 2019 | +107% |
| 2018 | −25% |
| 2017 | −31% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 9 of 10 | +58% |
| Feb | 10 | 2 of 10 | −4.0% |
| Mar | 10 | 4 of 10 | +1.6% |
| Apr | 10 | 6 of 10 | +7.2% |
| May | 10 | 5 of 10 | −3.2% |
| Jun | 10 | 4 of 10 | −0.22% |
| Jul | 11 | 5 of 11 | +3.2% |
| Aug | 11 | 4 of 11 | −4.8% |
| Sep | 11 | 2 of 11 | −10% |
| Oct | 11 | 1 of 11 | −7.4% |
| Nov | 10 | 2 of 10 | −0.74% |
| Dec | 10 | 5 of 10 | −1.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.